Prader-willi Syndrome

• FDA label_change · 2024-08-16
  FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved a supplemental application for Genotropin (somatropin) from Pfizer, resulting in changes to the labeling. The notice reflects t…

• FDA label_change · 2017-05-24
  FDA Approved: SEROSTIM — Supplemental Application (EMD Serono, Inc.)

  FDA approved a supplemental application for SEROSTIM (somatropin) from EMD Serono, Inc. to update the product labeling. The changes expand o…